Generation of IL-23 producing dendritic cells (DCs) by airborne fungi regulates fungal pathogenicity via the induction of TH-17 responses

Abstract

Interleukin-17 (IL-17) producing T helper cells (TH-17) comprise a newly recognized T cell subset with an emerging role in adaptive immunity to a variety of fungi. Whether different airborne fungi trigger a common signaling pathway for TH-17 induction, and whether this ability is related to the inherent pathogenic behavior of each fungus is currently unknown. Here we show that, as opposed to primary pathogenic fungi (Histoplasma capsulatum), opportunistic fungal pathogens (Aspergillus and Rhizopus) trigger a common innate sensing pathway in human dendritic cells (DCs) that results in robust production of IL-23 and drives TH-17 responses. This response requires activation of dectin-1 by the fungal cell wall polysaccharide b-glucan that is selectively exposed during the invasive growth of opportunistic fungi. Notably, unmasking of b-glucan in the cell wall of a mutant of Histoplasma not only abrogates the pathogenicity of this fungus, but also triggers the induction of IL-23 producing DCs. Thus, b-glucan exposure in the fungal cell wall is essential for the induction of IL-23/ TH-17 axis and may represent a key factor that regulates protective immunity to opportunistic but not pathogenic fungi. Citation: Chamilos G, Ganguly D, Lande R, Gregorio J, Meller S, et al. (2010) Generation of IL-23 Producing Dendritic Cells (DCs) by Airborne Fungi Regulates Fungal Pathogenicity via the Induction of TH-17 Responses. PLoS ONE 5(9): e12955. doi:10.1371/journal.pone.0012955 Editor: Eleftherios Mylonakis, Massachusetts General Hospital, United States of America Received May 4, 2010; Accepted August 31, 2010; Published September 23, 2010 Copyright:  2010 Chamilos et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This work was supported by a grant of the DANA Foundation (to M.G.), the M.D. Anderson Cancer Center Core Grant (CA16672) from the University of Texas (to D.P.K.), and the N.I.H. research grant AI25584 (to W.E.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: mgilliet@mdanderson.org (MG); dkontoyi@mdanderson.org (DPK)

Key Biomarkers